ORIONIS BIOSCIENCES
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation. The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initial internal focus in oncology and immunotherapies. Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.
ORIONIS BIOSCIENCES
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2015-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.orionisbio.com
Total Employee:
11+
Status:
Active
Total Funding:
24.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Google Maps Yoast SEO Premium Yoast Plugins
Similar Organizations
BALX Holdings
Balx Holdings operates in the healthcare industry focusing on biotechnology business.
Cannara Biotech
Cannara Biotech is to operate the largest indoor medical cannabis cultivation facility.
Centrexion
Centrexion operates in the healthcare industry, focusing on the biotechnology business.
Functional Fluidics
Functional Fluidics specializes in the standardization of clinical blood function assays to assess individual patient response.
Karuna Health
Karuna connects patients with healthcare guides through streamlined communication and automation.
Nido Biosciences
Nido Biosciences currently operates in healthcare services.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Rocket Pharmaceuticals
Rocket Pharmaceuticals Ltd. operates in the healthcare industry focusing on biotechnology business.
Sidero Bioscience
Sidero Bioscience operates in the healthcare industry focusing on biotechnology business.
Sunbeam
Sunbeam Holdings, L.P. operates in the healthcare industry. Sunbeam Holdings, L.P. was incorporated in 2007 and is based in Sunrise,
Symic Biomedical
SYMIC Biomedical operates in the healthcare industry focusing on biotechnology business.
Vetica Labs
Vetica Labs is operates in the healthcare industry focusing on biotechnology business.
Current Employees Featured
Founder
Investors List
Excel Venture Management
Excel Venture Management investment in Private Equity Round - Orionis Biosciences
CB Health Ventures
CB Health Ventures investment in Private Equity Round - Orionis Biosciences
Solasta Ventures
Solasta Ventures investment in Series B - Orionis Biosciences
V-Bio Ventures
V-Bio Ventures investment in Series B - Orionis Biosciences
Empire Angels
Empire Angels investment in Series B - Orionis Biosciences
Matias de Tezanos
Matias de Tezanos investment in Venture Round - Orionis Biosciences
V-Bio Ventures
V-Bio Ventures investment in Series A - Orionis Biosciences
Official Site Inspections
http://www.orionisbio.com
- Host name: 126.25.167.72.host.secureserver.net
- IP address: 72.167.25.126
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Orionis Biosciences"
About Us - Orionis Biosciences
During his tenure at Macrolide, Andy helped lead the company from early stage proof of concept to a development stage organization. He was responsible for strategic planning and capital …See details»
Contact - Orionis Biosciences
[email protected]. US Office Belgium Office . Contact US Office . Orionis Biosciences Inc 950 Winter Street Waltham, MA 02451. Contact Belgium Office . Orionis Biosciences BV …See details»
Orionis Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Orionis Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 23 news, and 1 literature, Disease Domain ...See details»
Orionis Biosciences - Crunchbase Company Profile & Funding
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation. The company is an early-stage drug discovery and development …See details»
Orionis Biosciences - LinkedIn
Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities.See details»
Orionis Biosciences | flanders.bio
Jan 9, 2015 [email protected] +32 9 261 06 51 Technologiepark 94 9052 Zwijnaarde BE Orionis Biosciences Foundation date 01/09/2015 Sector #Biotechnology - Therapeutics …See details»
Orionis Biosciences - LinkedIn
Orionis Biosciences | 3,351 followers on LinkedIn. Precision through target visibility and tunable design | Orionis Biosciences is a life sciences company pioneering technological innovation in …See details»
Orionis Biosciences Secures $55 Million Financing to Support ...
Oct 19, 2022 Orionis has multiple first-in-class immunotherapies in development for the treatment of cancer. Learn more at www.orionisbio.com. Contacts. Media: ...See details»
V-Bio Ventures portfolio company Orionis Biosciences …
Sep 20, 2023 The company is advancing a deep and diversified pipeline of drug modalities, including agents that engage components of the adaptive and innate immune systems with high precision, creating new avenues for the …See details»
Pipeline - Orionis Biosciences
Our A-Kine programs incorporate interferon (IFN), interleukin (IL) and tumor necrosis factor (TNF) cytokine families and have been engineered to selectively interact with targets indicated in the …See details»
MD Anderson’s Therapeutics Discovery Division, Orionis …
Mar 9, 2021 Orionis Biosciences Madeline Davidshofer MacDougall [email protected] 781-235-3060 MD Anderson Clayton R. Boldt, Ph.D. [email protected] 713-792-9518 Site …See details»
Orionis Biosciences Announces Collaboration with Genentech
Sep 20, 2023 The company is advancing a deep and diversified pipeline of drug modalities, including agents that engage components of the adaptive and innate immune systems with …See details»
Orionis Biosciences Debuts with Major Pharmaceutical …
Mar 5, 2020 Madeline Davidshofer MacDougall [email protected] 781-235-3060 Release Summary. Orionis Biosciences is today debuting with the announcement of a major drug …See details»
Orionis Biosciences Announces First Patient Dosed in Phase 1
Nov 15, 2023 BOSTON & GHENT, Belgium--(BUSINESS WIRE)-- Orionis Biosciences, a life sciences company pioneering the creation of highly selective and tunable therapeutics for …See details»
Approach in drug discovery - Orionis Biosciences
Our programs target multiple stages and components of the CIC to restore immune attack against cancer – from detection of cancer cells to promoters of tumor antigen processing, T and NK …See details»
Orionis Biosciences Debuts with Major Pharmaceutical Collaboration
Mar 5, 2020 Learn more at www.orionisbio.com. Media Contact: Madeline Davidshofer [email protected] 781-235-3060. US Office. Orionis Biosciences Inc 950 Winter Street …See details»
Orionis Biosciences Announces Collaboration with Genentech to …
Sep 20, 2023 Orionis to receive $47 million upfront, as well as future milestone-related payments. Orionis will leverage its Allo-Glue™ platform for discovery of small molecule …See details»
Orionis Biosciences Announces First Patient Dosed in Phase 1 …
Nov 15, 2023 Dose-escalation study to evaluate ORB-011 as single agent, with initial safety, pharmacokinetic and mechanism-based pharmacodynamic readouts. Tony Fadell, inventor of …See details»
News - Orionis Biosciences
Nov 14, 2022 Dose-escalation study to evaluate ORB-011 as single agent, with initial safety, pharmacokinetic and mechanism-based pharmacodynamic readouts. Tony Fadell, inventor of …See details»